According to Agenus 's latest financial reports the company's current earnings (TTM) are -$0.16 B. an increase over its 2022 earnings that were of -$0.17 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$0.16 B | -5.5% |
2022 | -$0.17 B | -556.26% |
2021 | $36.99 M | -130.37% |
2020 | -$0.13 B | 73.75% |
2019 | -$70.11 M | -48.74% |
2018 | -$0.14 B | 34.32% |
2017 | -$0.11 B | -7.16% |
2016 | -$0.11 B | 26.55% |
2015 | -$86.67 M | 110.24% |
2014 | -$41.23 M | 49.12% |
2013 | -$27.65 M | |
2011 | -$19.09 M | -12.25% |
2010 | -$21.76 M | -21.41% |
2009 | -$27.68 M | -26.86% |
2008 | -$37.85 M | 13.72% |
2007 | -$33.28 M | -33.4% |
2006 | -$49.97 M | -31.84% |
2005 | -$73.31 M | 9.74% |
2004 | -$66.8 M | -0.8% |
2003 | -$67.35 M | 17.37% |
2002 | -$57.38 M | 37.83% |
2001 | -$41.63 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | -10,739.95% | ๐บ๐ธ USA |
Merck MRK | $3.03 B | -2,002.68% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $8.44 B | -5,391.14% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $7.53 B | -4,823.80% | ๐ฌ๐ง UK |
Celldex Therapeutics CLDX | -$0.15 B | -10.95% | ๐บ๐ธ USA |